cover
Contact Name
Mohammad Saifur Rohman
Contact Email
hsj@ub.ac.id
Phone
+628973247705
Journal Mail Official
hsj@ub.ac.id
Editorial Address
Department of Cardiology and Vascular Medicine, Dr. Saiful Anwar General Hospital, 3rd Floor CVCU Jl. Jaksa Agung Suprapto No. 2, Malang, Indonesia
Location
Kota malang,
Jawa timur
INDONESIA
Heart Science Journal
Published by Universitas Brawijaya
Core Subject : Health, Science,
HEART SCIENCE is the official open access journal of Brawijaya Cardiovascular Research Center, Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia. The journal publishes articles three times per year in January, May, and September. The journal is a peer reviewed publication and accepts articles for publication from across the world. HEART SCIENCE accepts and publishes articles in the English language only. The primary goal of this journal is to publish clinical and basic research relevant to cardiovascular medicine. The journal covers the following topics: clinical cardiology, interventional cardiology, intensive and acute cardiovascular care, vascular diseases, non-invasive cardiology, pediatric cardiology, cardiac nuclear medicine imaging, arrhythmia, cardiac prevention and rehabilitation, and cardiac surgery. Animal studies are also considered for publication in HEART SCIENCE. To serve the interest of both practicing clinicians and researchers, the journal provides platform or forum for research scholars, intellectuals, and cardiologists to reveal their views and research work for dialogue, education, and interaction to the entire world. HEART SCIENCE publishes original research, reviews, brief reports, case reports, case series, editorial, and commentary. HEART SCIENCE also publishes the special issues and abstracts of papers presented at the annual meeting of the Cardiological Society of Malang.
Articles 383 Documents
Unmasking brugada syndrome: Baseline r′-wave triangle base duration and beta-angle in oral flecainide challenge positivity Raharjo, Sunu Budhi; Posangi, Ira; Hanafy, Dicky Armein; Hermanto, Dony Yugo; Waliyuddin, Ridwan Rasyid; Balqis, Indira Aura; Lin, Chin-Yu; Yuniadi, Yoga
Heart Science Journal Vol. 7 No. 4 (2026): Navigating High-Risk Cardiovascular Subsets: Premature Disease, Plaque Complexi
Publisher : Universitas Brawijaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21776/ub.hsj.2026.007.04.10

Abstract

Background: Electrocardiographic markers, including the r′-wave triangle base duration and beta-angle, have been proposed as adjunctive indicators of Brugada syndrome (BrS). As flecainide challenge testing (FCT) carries potential risks, baseline ECG predictors may refine pre-test risk stratification, although their relationship with oral flecainide challenge positivity remains uncertain.Objective: To evaluate whether baseline r′-wave triangle base duration and beta-angle were associated with FCT positivity.Methods:  This retrospective, single-center review included consecutive patients who underwent oral flecainide challenge within a historical institutional diagnostic pathway between September 2023 and September 2025. Baseline right-precordial ECG measurements, including r′-wave triangle base duration and beta-angle, were obtained from archived standard 12-lead tracings. The primary outcome was FCT positivity, defined as the emergence of a diagnostic type 1 Brugada patternResult: Among 40 included patients, 28 had a positive oral flecainide challenge result and 12 had a negative result.  In exploratory analyses, larger baseline β-angle and longer r′-wave triangle base duration were associated with oral flecainide challenge positivity. Mean β-angle was 36.07° ± 15.86° in positive versus 21.83° ± 10.72° in negative challenges (p=0.007); mean r′-wave triangle base duration was 161.6 ± 92.8 ms versus 81.6 ± 38.0 ms, respectively (p<0.001).  ROC analysis showed moderate discriminatory performance (AUC 0.756 for β-angle, 0.769 for r′-wave). Sample-derived thresholds of 27.5° and 2.625 mm (105 ms) yielded sensitivity of 71.4% and specificity of 83.3%. A combined model incorporating both parameters showed an AUC of 0.780 (95% CI, 0.635–0.924), with 75.0% sensitivity and 83.3% specificity at the Youden-optimal threshold. Conclusion: Baseline r′-wave triangle base duration and beta-angle were associated with FCT positivity. These findings support further prospective investigation using standardized ECG acquisition and contemporary provocation protocols.
Giant right coronary artery aneurysm in a patient with prior abdominal aortic aneurysm repair: A case report Dewi, Sutanti Lara; Widito, Sasmojo; Rahimah, Anna Fuji
Heart Science Journal Vol. 7 No. 4 (2026): Navigating High-Risk Cardiovascular Subsets: Premature Disease, Plaque Complexi
Publisher : Universitas Brawijaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21776/ub.hsj.2026.007.04.18

Abstract

Background: Coronary artery aneurysms (CAAs) are uncommon, giant forms are extremely rare and the presentation is nonspecific and may mimic other thoracic pathologies. Case Illustration: A 60-year-old male presented with progressive dyspnea, orthopnea, and peripheral edema, five years after open repair of a large fusiform abdominal aortic aneurysm. Echocardiography showed severe left ventricular dysfunction (LVEF 25%) with a mass at the junction of the right atrium and right ventricle, interpreted as a right atrial pseudoaneurysm. CT, however, described an isolated mediastinal mass. Coronary angiography showed a single giant saccular right coronary artery aneurysm (73.1 × 66.9 mm) with trapped contrast and chronic total occlusion of the left main and anterior descending arteries. CT reconstruction indicated the latter occlusion to be a second thrombus-laden coronary aneurysm, to be further evaluated. His previous aortic aneurysm suggested a common predisposition to aneurysms not appreciated during years of disrupted follow-up. He was treated with guideline-directed heart failure, antithrombotic, statin and metabolic therapy. Staged repair was deferred until stabilization. Conclusions: This case demonstrates how a pre-existing diagnosed abdominal aortic aneurysm may mask the recognition of a second coronary aneurysm and perhaps a third in the left coronary system. It emphasizes the importance of considering systemic aneurysmal predisposition in atypical thoracic masses in patients with a history of aortic aneurysm and the role of angiography with cross-sectional imaging in diagnosis.
The continuum of cardiovascular vulnerability: From premature atherosclerosis to heavily calcified lesions Munawar, Muhammad
Heart Science Journal Vol. 7 No. 4 (2026): Navigating High-Risk Cardiovascular Subsets: Premature Disease, Plaque Complexi
Publisher : Universitas Brawijaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21776/ub.hsj.2026.007.04.1

Abstract

Coronary atherosclerosis encompasses premature clinical events and heavily calcified lesions that complicate percutaneous coronary intervention (PCI). This editorial examines overlapping biological and procedural vulnerabilities and implications for prevention and intervention. Cumulative exposure to apolipoprotein B-containing lipoproteins, alongside inherited and acquired risk factors, drives atherosclerosis. Plaque inflammation, disruption, healing, fibrosis, and mineralization are dynamic processes, not an inevitable linear sequence. Biological vulnerability concerns the propensity for rupture, erosion, and thrombosis; procedural vulnerability concerns treatment complexity and complications when PCI is clinically indicated. Calcified nodules may confer both forms of vulnerability. Macrocalcification may reflect an adaptive healing response that stabilizes plaques, whereas microcalcification may promote vulnerability. Extensive coronary calcium nevertheless marks cumulative atherosclerotic burden, and lesion calcification complicates PCI. Risk assessment should integrate systemic risk, plaque burden, morphology, and clinical context. Intensive lipid lowering, risk-factor control, and adherence remain essential. Coronary imaging can refine risk assessment and guide lesion preparation, but neither high-risk plaque features nor heavy calcification alone establishes an indication for PCI. In PREVENT, preventive PCI plus optimal medical therapy reduced a composite endpoint in selected patients with non-flow-limiting, imaging-defined high-risk plaques; this does not establish a definitive reduction in death or spontaneous myocardial infarction. Indonesian priorities include earlier recognition of severe hypercholesterolemia, tobacco control, access to lipid-lowering therapy, and follow-up. Conclusion: This continuum supports lifelong prevention and selectively indicated, imaging-informed intervention, prioritizing patient outcomes over plaque detection or stent implantation.

Filter by Year

2020 2026


Filter By Issues
All Issue Vol. 7 No. 4 (2026): Navigating High-Risk Cardiovascular Subsets: Premature Disease, Plaque Complexi Vol. 7 No. 3 (2026): Predicting Restenosis in Coronary Artery Disease Vol. 7 No. 2 (2026): The Evolving Landscape of Heart Failure Vol. 7 No. 1 (2026): Accelerating Clinical Breakthroughs: The Journey from Molecular Discovery to Pa Vol. 6 No. 4 (2025): The Pursuit of Precision: Navigating Risks, Refining Diagnosis, and Securing Lo Vol. 6 No. 3 (2025): Advancements in Cardiac Imaging : Unlocking New Perspectives on the Heart Visua Vol. 6 No. 2 (2025): The Complexity in the Management of Heart Rhythm Disorder Vol. 6 No. 1 (2025): Challenges in Managing Acute Heart Failure Vol. 6 No. Suppl_July (2025): Supplement Issue : Indonesian Acute Coronary Syndrome Summit in Conjun Vol. 5 No. 4 (2024): The Current Perspective About Cardiometabolic Disease Vol. 5 No. 3 (2024): The Science and Art of Revascularization in Acute Coronary Syndrome Vol. 5 No. 2 (2024): Challenges in the Management of Congenital Heart and Structural Heart Diseases Vol. 5 No. 1 (2024): Inflammation and Cardiovascular Disease Vol. 4 No. 4 (2023): The Science and Art of Caring for Critically III Patients in Intensive Cardiac Vol. 4 No. 3 (2023): The Essensial Role of the Metabolic Syndrome in the Development of Cardiovascul Vol 4, No 2 (2023): Dealing with the Complexity of the Wide Spectrum of Cardiovascular Disease Vol. 4 No. 1 (2023): Optimizing Outcome in Acute Cardiac Care Vol 4, No 1 (2023): Optimizing Outcome in Acute Cardiac Care Vol. 3 No. 4 (2022): Prevention, Screening dan Rehabilitation : The Back Bone of Quality Care Improv Vol 3, No 4 (2022): Prevention, Screening dan Rehabilitation : The Back Bone of Quality Care Improve Vol. 3 No. 3 (2022): Cardiovascular Disease in Young Adulthood: Who, When, and How to Screen? Vol 3, No 3 (2022): Cardiovascular Disease in Young Adulthood: Who, When, and How to Screen? Vol 3, No 2 (2022): Improving ST-Elevation Myocardial Infraction Patients Prognosis Vol 3, No 1 (2022): Assesment and Outcome of Coronary Artery Disease in the Reperfusion Era Vol 2, No 4 (2021): Management of Thrombosis in Covid-19 Patient with Cardiovascular Disease Vol 2, No 3 (2021): The Science and Art of Myocardial Revascularization Vol 2, No 2 (2021): Dealing with Vascular Disease Vol 2, No 1 (2021): How to Diagnose Heart Failure and Deal with The Treatment Complexity Vol 1, No 4 (2020): Acute Coronary Syndrome in Daily Practice : Diagnosis, Complication, and Managem Vol 1, No 3 (2020): Management of Coronary Artery Disease: From Risk Factors to The Better Long-Term Vol 1, No 2 (2020): The Assessment of Diagnostic and Treatment Modality in Heart Failure Vol 1, No 1 (2020): The Importance of Adherence to The Guidelines More Issue